These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36823756)
21. Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells. Shi X; Quan Y; Wang Y; Wang Y; Li Y Bioorg Med Chem Lett; 2021 Feb; 33():127725. PubMed ID: 33316409 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as dual PI3Kα/mTOR inhibitors. Lei F; Sun C; Xu S; Wang Q; OuYang Y; Chen C; Xia H; Wang L; Zheng P; Zhu W Eur J Med Chem; 2016 Jun; 116():27-35. PubMed ID: 27043268 [TBL] [Abstract][Full Text] [Related]
23. New Oxazolo[5,4- Sochacka-Ćwikła A; Mączyński M; Czyżnikowska Ż; Wiatrak B; Jęśkowiak I; Czerski A; Regiec A Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232997 [TBL] [Abstract][Full Text] [Related]
24. Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors. Dong R; Zhou X; Wang M; Li W; Zhang JY; Zheng X; Tang KX; Sun LP Bioorg Med Chem; 2021 Jan; 29():115876. PubMed ID: 33246255 [TBL] [Abstract][Full Text] [Related]
26. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors. Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor. Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165 [TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies. El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271 [TBL] [Abstract][Full Text] [Related]
29. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies. Murahari M; Prakash KV; Peters GJ; Mayur YC Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel 5,6-dihydropyrimido[4,5-f]quinazoline derivatives as potent CDK2 inhibitors. Hu X; Zhao H; Wang Y; Liu Z; Feng B; Tang C Bioorg Med Chem Lett; 2018 Nov; 28(20):3385-3390. PubMed ID: 30197029 [TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors. Zhang JQ; Luo YJ; Xiong YS; Yu Y; Tu ZC; Long ZJ; Lai XJ; Chen HX; Luo Y; Weng J; Lu G J Med Chem; 2016 Aug; 59(15):7268-74. PubMed ID: 27427973 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold. Wang Q; Li X; Sun C; Zhang B; Zheng P; Zhu W; Xu S Molecules; 2017 Oct; 22(11):. PubMed ID: 29088090 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity. Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity. Ali GME; Ibrahim DA; Elmetwali AM; Ismail NSM Bioorg Chem; 2019 May; 86():1-14. PubMed ID: 30682722 [TBL] [Abstract][Full Text] [Related]
35. Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations. Cao M; Chen Y; Zhao T; Wei S; Guo M; Zhai X Bioorg Med Chem; 2020 Oct; 28(20):115715. PubMed ID: 33069079 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies. Joshi A; Bhojwani H; Wagal O; Begwani K; Joshi U; Sathaye S; Kanchan D Anticancer Agents Med Chem; 2022; 22(2):328-343. PubMed ID: 33858315 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers. Metwally NH; Mohamed MS; Ragb EA Bioorg Chem; 2019 Jul; 88():102929. PubMed ID: 31015179 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors. Sun W; Hu S; Fang S; Yan H Bioorg Chem; 2018 Aug; 78():393-405. PubMed ID: 29677483 [TBL] [Abstract][Full Text] [Related]
40. Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model. Vignaroli G; Iovenitti G; Zamperini C; Coniglio F; Calandro P; Molinari A; Fallacara AL; Sartucci A; Calgani A; Colecchia D; Mancini A; Festuccia C; Dreassi E; Valoti M; Musumeci F; Chiariello M; Angelucci A; Botta M; Schenone S J Med Chem; 2017 Jul; 60(14):6305-6320. PubMed ID: 28650650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]